Supply Chain | April 17, 2026
Syntegon reports record FY25 Results; revenue rises 10% to €1.75 billion
The company allocated €56 million to research and development for next-generation line solutions
The company allocated €56 million to research and development for next-generation line solutions
he innovation could pave the way for early and low-cost screening of smoking exposure and second-hand smoke biomarkers
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
Dr Desai argued that the sector is undergoing a structural acceleration in how quickly science turns into treatments
Exclusive distribution pact with Amcor broadens access to Parafilm M sealing solutions for laboratories, horticulture and industrial users
Move amid evidence of widespread reporting gaps
Backed by funding from an NIHR Doctoral Award, the guidance is focused on spotting abdominal tumours
Scientists at the forum warned of an increasingly volatile health landscape
At the centre of this shift is Eli Lilly and Company, whose latest investments in China and Japan are helping redefine the next phase of GLP-1 supply strategy
The solution integrates key molecular cloning methods—including Golden Gate, Gibson assembly, and restriction/ligation—alongside primer design, Sanger sequencing analysis, and protein translation in a single application
Subscribe To Our Newsletter & Stay Updated
